Telephone Counseling or Standard Care in Patients Who Have Completed Treatment for Stages I, II, or III Cervical Cancer
Completed · Not applicable
Conditions studied: Cervical Cancer, Psychosocial Effects of Cancer and Its Treatment
In brief
RATIONALE: Telephone counseling after treatment may reduce stress and improve the well-being and quality of life of patients who have cervical cancer. Changes in quality of life may be related to changes in immune function and neuroendocrine function. PURPOSE: This randomized phase I trial is studying how well telephone counseling works compared to standard care in reducing stress in patients who have completed treatment for stage I, stage II, or stage III cervical cancer.
Key facts
- Study ID
- NCT00086242
- Run by
- University of California, Irvine
- People needed
- 36
- Starts
- 2004-08-01
- Expected to finish
- 2007-06-30
- Last updated by the study team
- 2019-03-08
Who can join
Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Disease Characteristics:
- Diagnosis of cervical cancer between the past 3-15 months
- Stage I-III disease
- Completed therapy for cervical cancer ≥ 1 month ago
- Not receiving ongoing treatment
- More than 4 weeks since prior immunotherapy
- More than 30 days since prior investigational drugs
- No prior biological response modifier
- No concurrent corticosteroids
- No concurrent immunosuppressive therapy
- Patient Characteristics:
- Resident of Orange, San Diego, or Imperial County in California
- English or Spanish speaking
- No serious acute or chronic illness
- Has access to a telephone
You may not qualify if…
- Disease Characteristics:
- Stage IV cervical carcinoma
- Have undergone previous treatment with a biological response modifier (inferferons, interleukins) or prior immunotherapy within four weeks of study enrollment
- Used investigational drugs within 30 days of execution of the informed consent
- Required corticosteroids or were under immune suppression for any reason including an organ allograft or HIV infection
- Patients with metastatic disease or ongoing treatment
- Any acute or chronic illness, including autoimmune states, as judged clinically significant by the investigators
- Patient Characteristics:
- Non-English or Spanish speakers
Where it is running
- UCI, Health Policy and Research Center — Irvine, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.